SCHEMBL23764666

SCHEMBL23764666

COC(CN1C(=O)C(=O)c2cc(F)ccc21)OC(C)OC(OC)OC

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 4/20 0.52
TRPA1 O75762 1/20 0.42
CHRM5 P08912 2/20 0.42
NSD2 O96028 1/20 0.41
ALDH1A1 P00352 5/20 0.39
ALDH3A1 P30838 4/20 0.39
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
CA12 O43570 2/20 0.37
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
CUL4A Q13619 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23764670 0.84 CHRM5 (0.55) CHRM5
SCHEMBL23764758 0.79 PARK7 (0.51) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL12930230 0.77 PARK7 (0.69) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764712 0.77 PARK7 (0.54) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764647 0.76 PARK7 (0.51) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764617 0.73 PARK7 (0.52) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764760 0.72 PARK7 (0.51) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764697 0.70 PARK7 (0.52) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL23764690 0.70 PARK7 (0.41) PARK7TRPA1CHRM5NSD2ALDH1A1
SCHEMBL20254404 0.70 PARK7 (1.00) PARK7CHRM5NSD2ALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021162650-A1 5-FLUORO/5-TRIFLUOROMETHOXY-1H-INDOLE-2,3-DIONE 3-(4-PHENYLTHIOSEMICARBAZONE) DERIVATIVES AS INTERLEUKIN 1 (IL-1) ANTAGONISTS AND ANTI-PYRETIC AND/OR ANTI-INFLAMMATORY AGENTS FOR USE IN TREATING E.G. BEHÇET'S DISEASE ISTANBUL UNIVERSITESI (TR) 2021-08-19 WO disclosed